title: Acquired factor VIII inhibitor in an HIV-infected patient after treatment with pegylated interferon-alpha 2a and ribavirin.
authors.forename: Simon
authors.initials: S
authors.lastname: Paul
authors.forename: Usman
authors.initials: U
authors.lastname: Javed
authors.forename: Robert
authors.initials: R
authors.lastname: Tevendale
authors.forename: Jill
authors.initials: J
authors.lastname: Lanford
authors.forename: Raymond
authors.initials: R
authors.lastname: Liu
mesh_terms: D000328:Adult; D000998:Antiviral Agents / Q000627:therapeutic use*; D005169:Factor VIII / Q000037:antagonists & inhibitors*; D015658:HIV Infections / Q000150:complications*; D006470:Hemorrhage / Q000517:prevention & control; D006526:Hepatitis C / Q000188:drug therapy; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use*; D008297:Male; D011092:Polyethylene Glycols / Q000627:therapeutic use*; D011994:Recombinant Proteins; D012254:Ribavirin / Q000627:therapeutic use*
chemical_list: D000998:Antiviral Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D011092:Polyethylene Glycols; D012254:Ribavirin; D005169:Factor VIII; C100416:peginterferon alfa-2a